Blog
Innovative Insights: Legal Updates in Life Sciences | Fourth Quarter 2025
The Trump administration’s “America First” agenda is reshaping pricing, manufacturing, and regulation of the pharmaceutical landscape, with a reported central objective of lowering U.S. drug prices by promoting stronger domestic supply chains and employing more assertive federal oversight of both foreign and domestic drug production….
By: Jones Day